ADAR1 Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

ADAR1 Capital Management’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-134,109	Closed	-$1.29M	–	265
2024 Q4	$1.29M	Buy	+134,109	New	+$700K	0.26%	68

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADAR1 Capital Management's PSTX Position: Q1 2025 in Review

ADAR1 Capital Management sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 134,109 shares — an estimated $1.29M sold.

ADAR1 Capital Management first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $1.29M in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

ADAR1 Capital Management reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
ADAR1 Capital Management sold 134,109 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $1.29M.
ADAR1 Capital Management first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
ADAR1 Capital Management's Poseida Therapeutics, Inc. Common Stock position peaked at $1.29M in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on ADAR1 Capital Management's 13F filing for Q1 2025, filed 15 May 2025.